$RGBP Small Molecules Targeting Cancer and Autoimmunity
Regen has identified and filed patents on small molecules that activate and inhibit a novel gene (NR2F6) which controls how the immune system reacts to cancer cells and to inflammatory responses.
Quote:
Key Turning Points
DAILY 52-WEEK
2nd Resistance Point 0.0011
1st Resistance Point 0.0010
Last Price 0.0010
1st Support Level 0.0009
2nd Support Level 0.0009
Regen has identified and filed patents on small molecules that activate and inhibit a novel gene (NR2F6) which controls how the immune system reacts to cancer cells and to inflammatory responses.
Quote:
Key Turning Points
DAILY 52-WEEK
2nd Resistance Point 0.0011
1st Resistance Point 0.0010
Last Price 0.0010
1st Support Level 0.0009
2nd Support Level 0.0009